Rao, K.V.U. and Shorgar, N. 2025. Development of a stability-indicating UPLC method for quantification of mirvetuximab soravtansine-gynx in pharmaceutical formulations using quality by design (QbD) principles. Journal of Applied Pharmaceutical Research. 13, 2 (Apr. 2025), 204-213. DOI:https://doi.org/10.69857/joapr.v13i2.977.